Breaking News Instant updates and real-time market news.

SHPG

Shire

$162.52

7.32 (4.72%)

, TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

07:35
04/19/18
04/19
07:35
04/19/18
07:35

Takeda said to offer GBP46.50 per share for Shire, Reuters reports

Takeda (TKPYY) has made an indicative takeover offer of about GBP46.50 per share to Shire (SHPG), Reuters reports, citing two sources, one of which has direct knowledge of the matter. Reference Link

SHPG

Shire

$162.52

7.32 (4.72%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

  • 21

    Dec

SHPG Shire
$162.52

7.32 (4.72%)

02/22/18
BOFA
02/22/18
NO CHANGE
BOFA
Buy
Shire post results weakness overdone, says BofA/Merrill
BofA/Merrill analyst Graham Parry believes Shire post results weakness is overdone and says shares remain undervalued. The analyst argued that cons EPS cuts are already priced in, and reiterates a Buy rating on the shares.
03/07/18
HCWC
03/07/18
NO CHANGE
Target $12
HCWC
Buy
Caladrius price target raised to $12 from $7 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for Caladrius Biosciences (CLBS) to $12 after the company acquired from Shire (SHPG) an exclusive worldwide license to data and regulatory filings for a late-stage CD34+ cell therapy program for the treatment of chronic myocardial ischemia targeting refractory angina. The deal "significantly enriches" Caladrius' existing pipeline and should provide an "additional attractive shot on goal" in the coming years, Selvaraju tells investors in a research note. He increased his valuation of the company to $120M from $60M and reiterates a Buy rating on the shares.
03/28/18
BOFA
03/28/18
NO CHANGE
BOFA
Buy
Still considerable value in Shire even in no Takeda bid scenario, says BofA/Merrill
BofA/Merrill analyst Graham Parry notes that Takeda (TKPYY) has said in a statement that it is considering an approach for Shire (SHPG) but that the consideration is at a preliminary and exploratory stage and no approach has been made to the board of Shire. The analyst continues to see considerable value in Shire with concerns over hemophilia more than priced into the stock and upsides from pipeline, notably SHP643 for HAE and SHP647 for Ulcerative colitis and Crohns, and the value of its plasma/immunology franchise overlooked. Even in a no bid scenario, Parry believes passage through hemophilia overhangs and increased awareness of the value in these assets should see Shire trade higher on 12-month view. He reiterates a Buy rating on Shire's shares.
03/29/18
JEFF
03/29/18
NO CHANGE
Target $172
JEFF
Buy
Shire investors may be amenable to $50B-plus bid, says Jefferies
With challenges in the hemophilia market near term, Shire (SHPG) investors could be amenable to another $50B-plus bid, similar to AbbVie's (ABBV) 2014 offer, Jefferies analyst David Steinberg tells investors in a research note. This would represent a 35% premium to Shire's recent near five-year low valuation, the analyst writes. He says "it remains to be seen" how Takeda Pharmaceutical (TKPYY) could structure a transaction for Shire given the companies' similar equity valuations. The analyst finds it possible that Takeda's disclosed interest could spark competitive bids from large cap pharma companies. He keeps a Buy rating on Shire with a $172 price target.
TKPYY Takeda Pharmaceutical
$0.00

(0.00%)

10/03/17
JMPS
10/03/17
NO CHANGE
Target $25
JMPS
Outperform
Myovant Phase 3 results further de-risk ongoing trials, says JMP Securities
After Myovant Sciences (MYOV) and partner Takeda (TKPYY) announced a Japanese study evaluating the efficacy and safety of relugolix to treat uterine fibroids met its primary endpoint, JMP Securities analyst Jason Butler said the results represent a "best case outcome" and have a clear positive read through to ongoing international Phase 3 trials in uterine fibroids and endometriosis. The analyst, who increased his view of the probability of success in UF and EM, raised his price target on Myovant shares to $25 from $23 and keeps an Outperform rating on the stock.
01/16/18
BTIG
01/16/18
DOWNGRADE
BTIG
Neutral
TiGenix downgraded at BTIG to Neutral on valuation
As noted earlier, BTIG analyst Timothy Chiang downgraded TiGenix (TIG) to Neutral from Buy, saying the run-up of 81% year to date in the stock price has exceeded his target and warrants a move to the sidelines. Chiang believes that the acquisition offer by Takeda (TKPYY) will pass the required regulatory review of TiGenix lead product Alofisei in the E.U., adding that there is now less than 5% difference in the stock price relative to the Takeda offer.

TODAY'S FREE FLY STORIES

VSAT

ViaSat

$61.75

-1.08 (-1.72%)

09:03
05/25/18
05/25
09:03
05/25/18
09:03
Recommendations
ViaSat analyst commentary  »

ViaSat price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$64.15

-0.02 (-0.03%)

09:02
05/25/18
05/25
09:02
05/25/18
09:02
Recommendations
Carnival analyst commentary  »

Carnival capacity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

GVA

Granite Construction

$57.18

-0.48 (-0.83%)

09:01
05/25/18
05/25
09:01
05/25/18
09:01
Recommendations
Granite Construction analyst commentary  »

Granite Construction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$22.26

-0.205 (-0.91%)

08:58
05/25/18
05/25
08:58
05/25/18
08:58
Technical Analysis
Technical Take: Fiat Chrysler falls on 4.8M vehicle U.S.-market recall »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKE

The Buckle

$25.75

0.65 (2.59%)

08:55
05/25/18
05/25
08:55
05/25/18
08:55
Technical Analysis
Technical Take: The Buckle slides lower after reporting earnings »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

BAC

Bank of America

$30.19

-0.26 (-0.85%)

, PBR

Petrobras

$12.77

-2.335 (-15.46%)

08:55
05/25/18
05/25
08:55
05/25/18
08:55
Options
Notable open interest changes for May 25th »

Thursday's total…

BAC

Bank of America

$30.19

-0.26 (-0.85%)

PBR

Petrobras

$12.77

-2.335 (-15.46%)

AAPL

Apple

$188.18

-0.18 (-0.10%)

AFSI

AmTrust

$13.73

-0.045 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

ROST

Ross Stores

$82.95

0.35 (0.42%)

08:52
05/25/18
05/25
08:52
05/25/18
08:52
Technical Analysis
Technical Take: Ross Stores falls after earnings »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$32.97

1 (3.13%)

, FL

Foot Locker

$46.38

1.35 (3.00%)

08:52
05/25/18
05/25
08:52
05/25/18
08:52
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Amarin (AMRN), up…

GPS

Gap

$32.97

1 (3.13%)

FL

Foot Locker

$46.38

1.35 (3.00%)

DECK

Deckers Brands

$103.63

0.8 (0.78%)

HIBB

Hibbett Sports

$28.95

0.6 (2.12%)

AMRN

Amarin

$3.04

0.04 (1.33%)

TEVA

Teva

$21.64

0.485 (2.29%)

BMRN

BioMarin

$88.30

-0.2 (-0.23%)

ZOES

Zoe's Kitchen

$14.48

-0.41 (-2.75%)

EGHT

8x8, Inc.

$22.00

0.35 (1.62%)

ADSK

Autodesk

$138.76

-0.54 (-0.39%)

SPLK

Splunk

$116.35

-0.2 (-0.17%)

CBB

Cincinnati Bell

$15.93

-0.225 (-1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 25

    May

  • 25

    May

  • 29

    May

  • 05

    Jun

  • 05

    Jun

  • 12

    Jun

  • 14

    Jun

  • 16

    Jun

  • 10

    Jul

  • 12

    Sep

LOMA

Loma Negra

$11.52

-1.47 (-11.32%)

08:51
05/25/18
05/25
08:51
05/25/18
08:51
Upgrade
Loma Negra rating change  »

Loma Negra upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOMA

Loma Negra

$11.52

-1.47 (-11.32%)

08:50
05/25/18
05/25
08:50
05/25/18
08:50
Hot Stocks
Loma Negra says not under investigation in Argentina for cartelization »

Loma Negra said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$272.87

-0.5 (-0.18%)

, SPX

S&P 500

$0.00

(0.00%)

08:49
05/25/18
05/25
08:49
05/25/18
08:49
General news
Trump says 'time will tell' after 'warm and productive' North Korean statement »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$272.87

-0.5 (-0.18%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLF

Herbalife Nutrition

$53.85

-0.14 (-0.26%)

08:47
05/25/18
05/25
08:47
05/25/18
08:47
Hot Stocks
Herbalife Nutrition announces preliminary results of self-tender offer »

Herbalife Nutrition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$22.26

-0.205 (-0.91%)

08:46
05/25/18
05/25
08:46
05/25/18
08:46
Hot Stocks
Fiat Chrysler recalls estimated 4.8M U.S.-market vehicles for software upgrade »

FCA US announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:45
05/25/18
05/25
08:45
05/25/18
08:45
Conference/Events
Federal Reserve Chairman Powell participates in a panel discussion »

Federal Reserve Chairman…

NOK

Nokia

$6.09

-0.01 (-0.16%)

, AAOI

Applied Optoelectronics

$33.91

0.24 (0.71%)

08:45
05/25/18
05/25
08:45
05/25/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

NOK

Nokia

$6.09

-0.01 (-0.16%)

AAOI

Applied Optoelectronics

$33.91

0.24 (0.71%)

MDXG

MiMedx

$8.86

-0.12 (-1.34%)

GERN

Geron

$4.81

0.14 (3.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

08:45
05/25/18
05/25
08:45
05/25/18
08:45
General news
Treasury Action: yields remained at low ebb »

Treasury Action: yields…

08:35
05/25/18
05/25
08:35
05/25/18
08:35
General news
U.S. durable goods orders fell 1.7% in April »

U.S. durable goods orders…

TIF

Tiffany

$126.44

0.3 (0.24%)

08:34
05/25/18
05/25
08:34
05/25/18
08:34
Recommendations
Tiffany analyst commentary  »

Tiffany price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

DECK

Deckers Brands

$103.63

0.8 (0.78%)

08:34
05/25/18
05/25
08:34
05/25/18
08:34
Technical Analysis
Technical Take: Deckers at new 52-week high after earnings, analyst action »

The company reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USNA

USANA

$116.75

-2.85 (-2.38%)

08:34
05/25/18
05/25
08:34
05/25/18
08:34
Hot Stocks
USANA clinical sciences team to be led by Rolando Maddela, Jessie Johnson »

USANA is announcing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$102.36

-1.08 (-1.04%)

08:33
05/25/18
05/25
08:33
05/25/18
08:33
Recommendations
Weibo analyst commentary  »

Weibo risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

HWC

Hancock Whitney Corporation

$51.60

-0.2 (-0.39%)

, BBRG

Bravo Brio Restaurant

$4.05

(0.00%)

08:30
05/25/18
05/25
08:30
05/25/18
08:30
Options
One new option listing and two option delistings on May 25th »

New option listings for…

HWC

Hancock Whitney Corporation

$51.60

-0.2 (-0.39%)

BBRG

Bravo Brio Restaurant

$4.05

(0.00%)

HBHC

Symbol changed to HWC

$51.60

-0.2 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:30
05/25/18
05/25
08:30
05/25/18
08:30
General news
Fed Chairman Powell will make an appearance »

Fed Chairman Powell will…

SPLK

Splunk

$116.35

-0.2 (-0.17%)

08:28
05/25/18
05/25
08:28
05/25/18
08:28
Recommendations
Splunk analyst commentary  »

Splunk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

FL

Foot Locker

$46.38

1.35 (3.00%)

08:27
05/25/18
05/25
08:27
05/25/18
08:27
Technical Analysis
Technical Take: Foot Locker sharply higher after earning beat, outlook »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.